symmetrical polar kinase inhibitors hill antitumor activity

摘要

symmetrical polar choline kinase inhibitors with antitumor activity. # The present invention relates to symmetrical bispyridinium polar compounds, and bisquinolinio bisquinuclidinio with a linker derived from 1,2-bis (p-tolyloxy) ethane kinase inhibitors choline, synthesis and use as antitumor drug.